AAPM VL-I-131 Patient Release, Dosimetry and New Therapies

2024 AAPM 66th Annual Meeting - Session: I-131 Patient Release, Dosimetry and New Therapies

This video is currently visible only to AAPM Members, Affiliates and Developing Country Educational Associates. Embargo periods are typically one year from the date the presentation was first published.

Combination I-131 Radio-Immuno-Therapy and Other New I-131 Therapies
David Adam, PhD, MS Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University

When you have finished the video, you may watch again, browse/search all videos, go back to the previous page, or watch another video in this session (see below). add this video to a playlist.

All videos in this session:

	Clinical Implementation of I-131, Including Special Precautions and Patient Release - Kenneth Cashon, MS AdventHealth Orlando
	Clinical Use of I-131 Imaging and Dosimetry - Catherine (Caffi) Meyer, PhD Oregon Health & Science Univ
	Q&A -

Graph includes member loads and excludes non-members. Include? A load is defined as someone coming to this page, not necesarily that they pressed play, or watched the entire presentation.

AAPM is the American Association of Physicists in Medicine.
1631 Prince Street
Alexandria, VA 22314
Phone 571-298-1300
Fax 571-298-1301 
Send general questions to 2025.aapm@aapm.org

AAPM's Privacy Policy
Use of the site constitutes your acceptance to its terms and conditions.

AAPM is a scientific, educational, and professional nonprofit organization devoted to the discipline of physics in medicine. The information provided in this website is offered for the benefit of its members and the general public, however, AAPM does not independently verify or substantiate the information provided on other websites that may be linked to this site.

AAPM Virtual Library

2024 AAPM 66th Annual Meeting - Session: I-131 Patient Release, Dosimetry and New Therapies

This video is currently visible only to AAPM Members, Affiliates and Developing Country Educational Associates. Embargo periods are typically one year from the date the presentation was first published.